Autophagy and liver ischemia-reperfusion injury

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Cursio, Raffaele ^a,b   Colosetti, Pascal ^b   Gugenheim, Jean ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARBAMAZEPINE; CHLOROQUINE; CISPLATIN; LITHIUM CHLORIDE; MELATONIN; PYRUVIC ACID; RAPAMYCIN; ROSIGLITAZONE; SCAFFOLD PROTEIN; TRIMETAZIDINE; UBIQUITIN; WORTMANNIN;

ANIMAL EXPERIMENT; AUTOPHAGY; COLD ISCHEMIA; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER ISCHEMIA; LIVER ISCHEMIA REPERFUSION INJURY; LIVER PROTECTION; MONITORING; NONHUMAN; PROTEIN BINDING; REPERFUSION INJURY; REVIEW; SIDE EFFECT; STEADY STATE; THERAPY EFFECT; WESTERN BLOTTING; ANIMAL; LIVER; LIVER DISEASE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; HUMANS; LIVER; LIVER DISEASES; REPERFUSION INJURY;

EID: 84926429986     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/417590     Document Type: Review

References (143)

1. H. Jaeschke, "Mechanisms of reperfusion injury after warm ischemia of the liver," Journal of Hepato-Biliary-Pancreatic Surgery, vol. 5, no. 4, pp. 402-408, 1998.
2. R. Cursio, "Caspase inhibition in liver transplantation: from basic research to clinical studies," HPB, vol. 12, no. 1, pp. 1-3, 2010.
3. H. Jaeschke, "Molecular mechanisms of hepatic ischemia-reper-fusion injury and preconditioning," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 284, no. 1, pp. G15-G26, 2003.
4. R. Cursio, Liver ischemia-reperfusion injury in the rat: role of nonparenchymal liver cells [Postdoctoral thesis on liver transplantation], University of Paris XI, Paris, France, 2002.
5. G. C. Velmahos, K. Toutouzas, R. Radin et al., "High success with nonoperative management of blunt hepatic trauma: the liver is a sturdy organ," Archives of Surgery, vol. 138, no. 5, pp. 475-481, 2003.
6. H. T. Hassoun, B. C. Kone, D. W. Mercer, F. G. Moody, N. W. Weisbrodt, and F. A. Moore, "Post-injury multiple organ failure: the role of the gut," Shock, vol. 15, no. 1, pp. 1-10, 2001.
7. J. Belghiti, K. Hiramatsu, S. Benoist, P. P. Massault, A. Sauvanet, and O. Farges, "Seven hundred forty-seven hepatectomiesinthe 1990s: an update to evaluate the actual risk of liver resection," Journal of the American College of Surgeons, vol. 191, no. 1, pp. 38-46, 2000.
8. P.-A. Clavien, M. Selzner, H. A. Rüdiger et al., "A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning," Annals of Surgery, vol. 238, no. 6, pp. 843-852, 2003.
9. P.-A. Clavien, P. R. C. Harvey, and S. M. Strasberg, "Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies," Transplantation, vol. 53, no. 5, pp. 957-978, 1992.
10. D. G. Farmer, F. Amersi, J. Kupiec-Weglinski, and R. W. Busuttil, "Current status of ischemia and reperfusion injury in the liver," Transplantation Reviews, vol. 14, no. 2, pp. 106-126, 2000.
11. C. Fondevila, R. W. Busuttil, and J. W. Kupiec-Weglinski, "Hepatic ischemia-reperfusion injury - a fresh look," Experimental and Molecular Pathology, vol. 74, no. 2, pp. 86-93, 2003.
12. M. Glanemann, J. M. Langrehr, B. J. Stange et al., "Clinical implications of hepatic preservation injury after adult liver transplantation," The American Journal of Transplantation, vol. 3, no. 8, pp. 1003-1009, 2003.
13. O. de Rougemont, K. Lehmann, and P.-A. Clavien, "Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver," Liver Transplantation, vol. 15, no. 10, pp. 1172-1182, 2009.
14. L. Sanchez-Urdazpal, G. J. Gores, E. M. Ward et al., "Ischemic-type biliary complications after orthotopic liver transplantation," Hepatology, vol. 16, no. 1, pp. 49-53, 1992.
15. C. I. Buis, H. Hoekstra, R. C. Verdonk, and R. J. Porte, "Causes and consequences of ischemic-type biliary lesions after liver transplantation," Journal of Hepato-Biliary-Pancreatic Surgery, vol. 13, no. 6, pp. 517-524, 2006.
16. R. Cursio and J. Gugenheim, "Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation," Journal of Transplantation, vol. 2012, Article ID 164329, 17 pages, 2012.
17. P. F. Halloran, "Call for revolution: a new approach to describing allograft deterioration," American Journal of Transplantation, vol. 2, no. 3, pp. 195-200, 2002.
18. S. Gourishankar and P. F. Halloran, "Late deterioration of organ transplants: a problem in injury and homeostasis," Current Opinion in Immunology, vol. 14, no. 5, pp. 576-583, 2002.
19. P.-A. Clavien, "How far can we go with marginal donors?" Journal of Hepatology, vol. 45, no. 4, pp. 483-484, 2006.
20. N. Selzner, H. Rudiger, R. Graf, and P.-A. Clavien, "Protective strategies against ischemic injury of the liver," Gastroenterology, vol. 125, no. 3, pp. 917-936, 2003.
21. H. Jaeschke and J. J. Lemasters, "Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury," Gastroenterology, vol. 125, no. 4, pp. 1246-1257, 2003.
22. J. J. Lemasters, A.-L. Nieminen, T. Qian et al., "The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy," Biochimica et Biophysica Acta, vol. 1366, no. 1-2, pp. 177-196, 1998.
23. J. J. Lemasters, "V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis," Te American Journal of Physiology, vol. 276, no. 1, part 1, pp. G1-G6, 1999.
24. R. Cursio, J. Gugenheim, J. E. Ricci et al., "A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis," The FASEB Journal, vol. 13, no. 2, pp. 253-261, 1999.
25. W. Gao, R. C. Bentley, J. E. Madden, and P.-A. Clavien, "Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation," Hepatology, vol. 27, no. 6, pp. 1652-1660, 1998.
26. Z. Lu, K. Dono, K. Gotoh et al., "Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation," Archives of Histolog y and Cytology, vol. 68, no. 1, pp. 71-80, 2005.
27. J.-S. Kim, T. Nitta, D. Mohuczy et al., "Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes," Hepatology, vol. 47, no. 5, pp. 1725-1736, 2008.
28. T. Shin, S. Kuboki, N. Huber et al., "Activation of peroxisome proliferator-activated receptor-γ during hepatic ischemia is age-dependent," Journal of Surgical Research, vol. 147, no. 2, pp. 200-205, 2008.
29. M.-C. Domart, D. D. Esposti, M. Sebagh et al., "Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy," Journal of Hepatology, vol. 51, no. 5, pp. 881-889, 2009.
30. T. Minor, J. Stegemann, A. Hirner, and M. Koetting, "Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning," Liver Transplantation, vol. 15, no. 7, pp. 798-805, 2009.
31. R. Cursio, P. Colosetti, M.-C. Saint-Paul et al., "Induction of different types of cell death after normothermic liver ischemiareperfusion," Transplantation Proceedings, vol. 42, no. 10, pp. 3977-3980, 2010.
32. J. Cardinal, P. Pan, M. Ross et al., "Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury," Hepatology, vol. 50, no. 2, pp. 565-574, 2009.
33. K. Gotoh, Z. Lu, M. Morita et al., "Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation," Autophagy, vol. 5, no. 3, pp. 351-360, 2009.
34. J. Wang, I. Ahn, T. D. Fischer et al., "Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice," Gastroenterology, vol. 141, no. 6, pp. 2188.e6-2199.e6, 2011.
35. D. Degli Esposti, M. Sebagh, P. Pham et al., "Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes," Cell Death and Disease, vol. 2, no. 1, article e111, 2011.
36. T. Minor, M. Koetting, G. Kaiser, P. Efferz, B. Lüer, and A. Paul, "Hypothermic reconditioning by gaseous oxygen improves survival after liver transplantation in the pig," American Journal of Transplantation, vol. 11, no. 12, pp. 2627-2634, 2011.
37. J. Evankovich, R. Zhang, J. S. Cardinal et al., "Calcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 2, pp. G189-G198, 2012.
38. D. Wang, Y. Ma, Z. Li et al., "The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice," Autophagy, vol. 8, no. 6, pp. 954-962, 2012.
39. R. H. Bhogal, C. J. Weston, S. M. Curbishley, D. H. Adams, and S. C. Afford, "Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress," Autophagy, vol. 8, no. 4, pp. 545-558, 2012.
40. J. Gracia-Sancho, H. García-Calderó, D. Hide et al., "Simvastatin maintains function and viability of steatotic rat livers procured for transplantation," Journal of Hepatology, vol. 58, no. 6, pp. 1140-1146, 2013.
41. M. A. Zaouali, E. Boncompagni, R. J. Reiter et al., "AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail," Journal of Pineal Research, vol. 55, no. 1, pp. 65-78, 2013.
42. A. Liu, H. Fang, U. Dahmen, and O. Dirsch, "Chronic lithium treatment protects against liver ischemia/reperfusion injury in rats," Liver Transplantation, vol. 19, no. 7, pp. 762-772, 2013.
43. K. Sun, X. Xie, Y. Liu et al., "Autophagy lessens ischemic liver injury by reducing oxidative damage," Cell & Bioscience, vol. 3, article 26, 2013.
44. H. Fang, A. Liu, U. Dahmen, and O. Dirsch, "Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase," Cell Death & Disease, vol. 4, article e694, 2013.
45. J.-S. Kim, J.-H. Wang, T. G. Biel et al., "Carbamazepine suppresses calpain-mediated autophagy impairment after ischemia/reperfusion in mouse livers," Toxicology and Applied Pharmacology, vol. 273, no. 3, pp. 600-610, 2013.
46. M. Shen, J. Lu, W. Dai et al., "Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy," Mediators of Inflammation, vol. 2013, Article ID 461536, 12 pages, 2013.
47. N. Yun, H.-I. Cho, and S.-M. Lee, "Impaired autophagy contributes to hepatocellular damage during ischemia/reperfusion: heme oxygenase-1 as a possible regulator," Free Radical Biology and Medicine, vol. 68, pp. 168-177, 2014.
48. J.-W. Kang, H.-I. Cho, and S.-M. Lee, "Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion," Cellular Physiology and Biochemistry, vol. 33, no. 1, pp. 23-36, 2014.
49. E. H. Baehrecke, "Autophagy: dual roles in life and death?" Nature Reviews. Molecular Cell Biology, vol. 6, no. 6, pp. 505-510, 2005.
50. D. J. Klionsky, "The molecular machinery of autophagy: unanswered questions," Journal of Cell Science, vol. 118, no. 1, pp. 7-18, 2005.
51. Y. Chen and D. J. Klionsky, "The regulation of autophagy-unanswered questions," Journal of Cell Science, vol. 124, no. 2, pp. 161-170, 2011.
52. P.-E. Rautou, A. Mansouri, D. Lebrec, F. Durand, D. Valla, and R. Moreau, "Autophagy in liver diseases," Journal of Hepatology, vol. 53, no. 6, pp. 1123-1134, 2010.
53. P. Codogno and A. J. Meijer, "Autophagy in the liver," Journal of Hepatology, vol. 59, no. 2, pp. 389-391, 2013.
54. M. J. Czaja, W.-X. Ding, T. M. Donohue Jr. et al., "Functions of autophagy in normal and diseased liver," Autophagy, vol. 9, no. 8, pp. 1131-1158, 2013.
55. X.-M. Yin, W.-X. Ding, and W. Gao, "Autophagy in the liver," Hepatology, vol. 47, no. 5, pp. 1773-1785, 2008.
56. D. J. Klionski, H. Abeliovich, P. Agostinis, D. K. Agrawal, and G. Aliev, "Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes," Autophagy, vol. 4, no. 2, pp. 151-175, 2008.
57. R. G. Thurman, I. Marzi, G. Seitz, J. Thies, J. J. Lemasters, and F. Zimmerman, "Hepatic reperfusion injury following orthotopic liver transplantation in the rat," Transplantation, vol. 46, no. 4, pp. 502-506, 1988.
58. C. M. B. McKeown, V. Edwards, M. J. Phillips, P. R. C. Harvey, C. N. Petrunka, and S. M. Strasberg, "Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat," Transplantation, vol. 46, no. 2, pp. 178-191, 1988.
59. J. C. Caldwell-Kenkel, R. T. Currin, Y. Tanaka, R. G. Thurman, and J. J. Lemasters, "Reperfusion injury to endothelial cells following ischemic storage of rat livers," Hepatology, vol. 10, no. 3, pp. 292-299, 1989.
60. M. Mendes-Braz, M. Elias-Miró, M. B. Jiménez-Castro, A. Casillas-Ramírez, F. S. Ramalho, and C. Peralta, "The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 298657, 20 pages, 2012.
61. J. J. Lemasters and R. G. Thurman, "Reperfusion injury after liver preservation for transplantation," Annual Review of Pharmacology and Toxicology, vol. 37, pp. 327-338, 1997.
62. E. E. Montalvo-Jave, T. Escalante-Tattersfield, J. A. Ortega-Salgado, E. Piña, and D. A. Geller, "Factors in the pathophysiology of the liver ischemia-reperfusion injury," Journal of Surgical Research, vol. 147, no. 1, pp. 153-159, 2008.
63. H. Jaeschke, A. Farhood, A. P. Bautista, Z. Spolarics, and J. J. Spitzer, "Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 264, no. 4, part 1, pp. G801-G809, 1993.
64. H. Jaeschke, "Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1083-G1088, 2006.
65. N. A. Essani, G. M. McGuire, A. M. Manning, and H. Jaeschke, "Endotoxin-induced activation of the nuclear transcription factor κB and expression of E-selectin messenger RNA in hepatocytes, kupffer cells, and endothelial cells in vivo," The Journal of Immunology, vol. 156, no. 8, pp. 2956-2963, 1996.
66. T. Matsumura, A. Ito, T. Takii, H. Hayashi, and K. Onozaki, "Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes," Journal of Interferon and Cytokine Research, vol. 20, no. 10, pp. 915-921, 2000.
67. N. C. Teoh, "Hepatic ischemia reperfusion injury: contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly," Journal of Gastroenterology and Hepatology, vol. 26, supplement 1, pp. 180-187, 2011.
68. B. Vollmar, J. Glasz, R. Leiderer, S. Post, and M. D. Menger, "Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion," The American Journal of Pathology, vol. 145, no. 6, pp. 1421-1431, 1994.
69. W. Zhou, M. O. McCollum, B. A. Levine, and M. S. Olson, "Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion," Hepatology, vol. 16, no. 5, pp. 1236-1240, 1992.
70. X. Qin and B. Gao, "The complement system in liver diseases," Cellular & Molecular Immunology, vol. 3, no. 5, pp. 333-340, 2006.
71. P. Boros and J. S. Bromberg, "New cellular and molecular immune pathways in ischemia/reperfusion injury," The American Journal of Transplantation, vol. 6, no. 4, pp. 652-658, 2006.
72. Y. Zhai, R. W. Busuttil, and J. W. Kupiec-Weglinski, "Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation," American Journal of Transplantation, vol. 11, no. 8, pp. 1563-1569, 2011.
73. Y. Zhai, H. Petrowsky, J. C. Hong, R. W. Busuttil, and J. W. Kupiec-Weglinski, "Ischaemia-reperfusion injury in liver transplantation-from bench to bedside," Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 2, pp. 79-89, 2013.
74. Y. Huang, H. Rabb, and K. L. Womer, "Ischemia-reperfusion and immediate T cell responses," Cellular Immunology, vol. 248, no. 1, pp. 4-11, 2007.
75. D. Linfert, T. Chowdhry, and H. Rabb, "Lymphocytes and ischemia-reperfusion injury," Transplantation Reviews, vol. 23, no. 1, pp. 1-10, 2009.
76. + T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 5, pp. G969-G976, 2005.
77. J.-S. Kim, T. Qian, and J. J. Lemasters, "Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes," Gastroenterology, vol. 124, no. 2, pp. 494-503, 2003.
78. R. Cursio, P. Colosetti, P. Auberger, and J. Gugenheim, "Autophagy and liver ischemia-reperfusion injury," in Autophagy: Principles, Regulation and Role in Diseases, pp. 297-328, Nova, New York, NY, USA, 2012.
79. Z. Xie and D. J. Klionsky, "Autophagosome formation: core machinery and adaptations," Nature Cell Biology, vol. 9, no. 10, pp. 1102-1109, 2007.
80. R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, "The Beclin 1 network regulates autophagy and apoptosis," Cell Death and Differentiation, vol. 18, no. 4, pp. 571-580, 2011.
81. S. A. Susin, H. K. Lorenzo, N. Zamzami et al., "Molecular characterization of mitochodrial apoptosis-inducing factor," Nature, vol. 397, no. 6718, pp. 441-446, 1999.
82. S. P. Elmore, T. Qian, S. F. Grissom, and J. J. Lemasters, "The mitochondrial permeability transition initiates autophagy in rat hepatocytes," The FASEB Journal, vol. 15, no. 12, pp. 2286-2287, 2001.
83. J. R. Klune and A. Tsung, "Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements," Surgical Clinics of North America, vol. 90, no. 4, pp. 665-677, 2010.
84. I. Ito, J. Fukazawa, and M. Yoshida, "Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils," The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16336-16344, 2007.
85. P. Scaffidi, T. Misteli, and M. E. Bianchi, "Release of chromatin protein HMGB1 by necrotic cells triggers inflammation," Nature, vol. 418, no. 6894, pp. 191-195, 2002.
86. S. Müller, P. Scaffidi, B. Degryse et al., "The double life of HMGB1 chromatin protein: architectural factor and extracellular signal," The EMBO Journal, vol. 20, no. 16, pp. 4337-4340, 2001.
87. A. Tsung, R. Sahai, H. Tanaka et al., "The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion," Journal of Experimental Medicine, vol. 201, no. 7, pp. 1135-1143, 2005.
88. A. Liu, H. Jin, O. Dirsch et al., "Release of danger signals during ischemic storage of the liver: a potential marker of organ damage?" Mediators of Inflammation, vol. 2010, Article ID 436145, 11 pages, 2010.
89. A. Liu, H. Fang, O. Dirsch, H. Jin, and U. Dahmen, "Oxidation of hmgb1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion," PLoS ONE, vol. 7, no. 4, Article ID e35379, 2012.
90. A. Liu, O. Dirsch, H. Fang et al., "HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat," Histochemistry and Cell Biology, vol. 135, no. 5, pp. 443-452, 2011.
91. M. Ilmakunnas, E. M. Tukiainen, A. Rouhiainen et al., "High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation," Liver Transplantation, vol. 14, no. 10, pp. 1517-1525, 2008.
92. S. Sarkar, R. A. Floto, Z. Berger et al., "Lithium induces autophagy by inhibiting inositol monophosphatase," The Journal of Cell Biology, vol. 170, no. 7, pp. 1101-1111, 2005.
93. C. J. Mullonkal and L. H. Toledo-Pereyra, "Akt in ischemia and reperfusion," Journal of Investigative Surgery, vol. 20, no. 3, pp. 195-203, 2007.
94. C. Müller, F. Dünschede, E. Koch, A. M. Vollmar, and A. K. Kiemer, "α-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 285, no. 4, pp. G769-G778, 2003.
95. R. Cursio, N. Filippa, C. Miele, E. Van Obberghen, and J. Gugenheim, "Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury," The British Journal of Surgery, vol. 93, no. 6, pp. 752-761, 2006.
96. X.L. Li, K. Man, K.T. Ng, C.K. Sun, C.M. Lo, and S.T. Fan, "The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation," American Journal of Transplantation, vol. 5, no. 6, pp. 1264-1275, 2005.
97. Y. Kurihara, T. Kanki, Y. Aoki et al., "Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast," The Journal of Biological Chemistry, vol. 287, no. 5, pp. 3265-3272, 2012.
98. A. M. Cuervo, E. Bergamini, U. T. Brunk, W. Dröge, M. Ffrench, and A. Terman, "Autophagy and aging: the importance of maintaining "clean" cells," Autophagy, vol. 1, no. 3, pp. 131-140, 2005.
99. S. Kuboki, T. Shin, N. Huber et al., "Peroxisome proliferator-activated receptor-γ protects against hepatic ischemia/reperfusion injury in mice," Hepatology, vol. 47, no. 1, pp. 215-224, 2008.
100. V. E. de Meijer, B. T. Kalish, M. Puder, and J. N. M. IJzermans, "Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection," British Journal of Surgery, vol. 97, no. 9, pp. 1331-1339, 2010.
101. D. J. Verran, T. Kusyk, D. Painter et al., "Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation," Liver Transplantation, vol. 9, no. 5, pp. 500-505, 2003.
102. P. Caraceni, C. Bianchi, M. Domenicali et al., "Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury," Journal of Hepatology, vol. 41, no. 1, pp. 82-88, 2004.
103. M. J. J. Chu, A. J. R. Hickey, A. R. J. Phillips, and A. S. J. R. Bartlett, "The impact of hepatic steatosis on hepatic ischemia-reperfusion injury in experimental studies: a systematic review," BioMed Research International, vol. 2013, Article ID 192029, 12 pages, 2013.
104. Y. Wang, R. Singh, Y. Xiang, and M. J. Czaja, "Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress," Hepatology, vol. 52, no. 1, pp. 266-277, 2010.
105. R. Singh, S. Kaushik, Y. Wang et al., "Autophagy regulates lipid metabolism," Nature, vol. 458, no. 7242, pp. 1131-1135, 2009.
106. T. Minor, S. Akbar, R. Tolba, and F. Dombrowski, "Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation," Journal of Hepatology, vol. 32, no. 1, pp. 105-111, 2000.
107. T. Minor and M. Kötting, "Gaseous oxygen for hypothermic preservation of predamaged liver grafts: fuel to cellular homeostasis or radical tissue alteration?" Cryobiology, vol. 40, no. 2, pp. 182-186, 2000.
108. R. Scherz-Shouval, Y. Sagiv, H. Shorer, and Z. Elazar, "The COOH terminus of GATE-16, an intra-golgi transport modulator, is cleaved by the human cysteine protease HsApg4A," The Journal of Biological Chemistry, vol. 278, no. 16, pp. 14053-14058, 2003.
109. C. Peralta, G. Hotter, D. Closa, E. Gelpí, O. Bulbena, and J. Roselló-Catafau, "Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine," Hepatology, vol. 25, no. 4, pp. 934-937, 1997.
110. P.-A. Clavien, S. Yadav, D. Sindram, and R. C. Bentley, "Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans," Annals of Surgery, vol. 232, no. 2, pp. 155-162, 2000.
111. H. Petrowsky, L. McCormack, M. Trujillo, M. Selzner, W. Jochum, and P.-A. Clavien, "A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection," Annals of Surgery, vol. 244, no. 6, pp. 921-928, 2006.
112. D. Azoulay, M. Del Gaudio, P. Andreani et al., "Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the Ying and the Yang," Annals of Surgery, vol. 242, no. 1, pp. 133-139, 2005.
113. K. S. Gurusamy, Y. Kumar, D. Sharma, and B. R. Davidson, "Ischaemic preconditioning for liver transplantation," The Cochrane Database of Systematic Reviews, vol. 21, no. 1, Article ID CD006315, 2008.
114. N. Selzner, M. Boehnert, and M. Selzner, "Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications," Transplantation Reviews, vol. 26, no. 2, pp. 115-124, 2012.
115. S. O'Neill, S. Leuschner, S. J. McNally, O. J. Garden, S. J. Wigmore, and E. M. Harrison, "Meta-analysis of ischaemic preconditioning for liver resections," The British Journal of Surgery, vol. 100, no. 13, pp. 1689-1700, 2013.
116. F. G. Fernandez, J. Ritter, J. W. Goodwin, D. C. Linehan, W. G. Hawkins, and S. M. Strasberg, "Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases," Journal of the American College of Surgeons, vol. 200, no. 6, pp. 845-853, 2005.
117. K. E. Behrns, G. G. Tsiotos, N. F. DeSouza, M. K. Krishna, J. Ludwig, and D. M. Nagorney, "Hepatic steatosis as a potential risk factor for major hepatic resection," Journal of Gastrointestinal Surgery, vol. 2, no. 3, pp. 292-298, 1998.
118. Y. Matsui, H. Takagi, X. Qu et al., "Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy," Circulation Research, vol. 100, no. 6, pp. 914-922, 2007.
119. M. Vairetti, A. Ferrigno, R. Bertone et al., "Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation," Journal of Pineal Research, vol. 38, no. 4, pp. 223-230, 2005.
120. I. Freitas, V. Bertone, C. Guarnaschelli et al., "In situ demonstration of improvement of liver mitochondria function by melatonin after cold ischemia," in vivo, vol. 20, no. 2, pp. 229-237, 2006.
121. L. Russo, J. Gracia-Sancho, H. García-Calderó et al., "Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers," Hepatology, vol. 55, no. 3, pp. 921-930, 2012.
122. R. Kang, K. M. Livesey, H. J. Zeh, M. T. Lotze, and D. Tang, "HMGB1: a novel Beclin 1-binding protein active in autophagy," Autophagy, vol. 6, no. 8, pp. 1209-1211, 2010.
123. P. P. Huebener, G.-E. Y. Gwak, J.-P. Pradere et al., "High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo," Cell Metabolism, vol. 19, pp. 539-547, 2014.
124. D. Tang, R. Kang, K. M. Livesey et al., "High-mobility group box 1 is essential for mitochondrial quality control," Cell Metabolism, vol. 13, no. 6, pp. 701-711, 2011.
125. R. Kang, K. M. Livesey, H. J. Zeh, M. T. Lotze, and D. Tang, "Metabolic regulation by HMGB1-mediated autophagy and mitophagy," Autophagy, vol. 7, no. 10, pp. 1256-1258, 2011.
126. H. Huang, G. W. Nace, K.-A. Mcdonald et al., "Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection," Hepatology, vol. 59, no. 5, pp. 1984-1997, 2014.
127. A. Rickenbacher, J. H. Jang, P. Limani et al., "Fasting protects liver from ischemic injury through Sirt1-mediated downregulation of circulating HMGB1 in mice," Journal of Hepatology, vol. 61, no. 2, pp. 301-308, 2014.
128. T. Karatzas, A.-A. Neri, M.-E. Baibaki, and I. A. Dontas, "Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms," Journal of Surgical Research, vol. 191, no. 2, pp. 399-412, 2014.
129. H. U. Spiegel and R. Bahde, "Experimental models of temporary normothermic liver ischemia," Journal of Investigative Surgery, vol. 19, no. 2, pp. 113-123, 2006.
130. N. Mizushima, T. Yoshimori, and B. Levine, "Methods in mammalian autophagy research," Cell, vol. 140, no. 3, pp. 313-326, 2010.
131. Y. Ohsumi, "Historical landmarks of autophagy research," Cell Research, vol. 24, no. 1, pp. 9-23, 2014.
132. J. M. Swanlund, K. C. Kregel, and T. D. Oberley, "Investigating autophagy: quantitative morphometric analysis using electron microscopy," Autophagy, vol. 6, no. 2, pp. 270-277, 2010.
133. D. C. Rubinsztein, A. M. Cuervo, B. Ravikumar et al., "In search of an "autophagomometer"," Autophagy, vol. 5, no. 5, pp. 585-589, 2009.
134. N. Mizushima and T. Yoshimori, "How to interpret LC3 immunoblotting," Autophagy, vol. 3, no. 6, pp. 542-545, 2007.
135. M. L. Seibenhener, T. Geetha, and M. W. Wooten, "Sequestosome 1/p62-more than just a scaffold," FEBS Letters, vol. 581, no. 2, pp. 175-179, 2007.
136. J. Moscat and M. T. Diaz-Meco, "p62 at the crossroads of autophagy, apoptosis, and cancer," Cell, vol. 137, no. 6, pp. 1001-1004, 2009.
137. F. Bardag-Gorce, T. Francis, L. Nan et al., "Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease," Life Sciences, vol. 77, no. 20, pp. 2594-2602, 2005.
138. K. Nakaso, Y. Yoshimoto, T. Nakano et al., "Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease," Brain Research, vol. 1012, no. 1-2, pp. 42-51, 2004.
139. E.-L. Eskelinen, "Maturation of autophagic vacuoles in mammalian cells," Autophagy, vol. 1, no. 1, pp. 1-10, 2005.
140. C. M. Hartford and M. J. Ratain, "Rapamycin: something old, something new, sometimes borrowed and now renewed," Clinical Pharmacology and Therapeutics, vol. 82, no. 4, pp. 381-388, 2007.
141. C. Takatsuka, Y. Inoue, K. Matsuoka, and Y. Moriyasu, "3-Methyladenine inhibits autophagy in tobacco culture cells under sucrose starvation conditions," Plant and Cell Physiology, vol. 45, no. 3, pp. 265-274, 2004.
142. Y.-T. Wu, H.-L. Tan, G. Shui et al., "Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase," Journal of Biological Chemistry, vol. 285, no. 14, pp. 10850-10861, 2010.
143. M. F. Ethier and J. M. Madison, "LY294002, but not wort-mannin, increases intracellular calcium and inhibits calcium transients in bovine and human airway smooth muscle cells," Cell Calcium, vol. 32, no. 1, pp. 31-38, 2002.